January 13, 2020 Liq. Handling & Robotics M&A, Partnerships

Waters to Acquire Andrew Alliance

Waters enables core product portfolio with next-generation automation technology MILFORD, Mass.–(BUSINESS WIRE)–Jan. 13, 2020– Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling... Read more

January 13, 2020 Clinical Research/Diagn. M&A, Partnerships

QIAGEN builds on global collaboration with Amgen for companion diagnostic development in non-small cell lung cancer

Hilden, Germany and Germantown, Maryland, January 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration to develop tissue-based companion diagnostics for Amgen’s investigational cancer treatment AMG 510 to identify patients with cancers that have the KRAS G12C mutation. The agreement focuses initially on companion diagnostics for non-small cell... Read more

January 13, 2020 Environ, Ag./Food & Bev Informatics & Software Licensing, IP, and Legal Life Science Tools M&A, Partnerships Microscopy Product Launch

Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. Speaking today at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco,... Read more

January 13, 2020 M&A, Partnerships

Roche and Illumina partner to broaden patient access to genomic testing

Partnership to leverage Illumina’s extensive decentralised installed base with Roche’s expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves clinical decision making by genomically defining a patient’s unique cancer and matching optimal treatment Collaboration agreement builds upon Roche’s sequencing strategy to accelerate clinical research, streamline workflows... Read more

January 7, 2020 Life Science Tools M&A, Partnerships

ERS Genomics announces agreement with New England Biolabs to commercialize CRISPR gene editing tools and reagents

License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA, (07 January 2020): ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs... Read more

January 6, 2020 Environ, Ag./Food & Bev M&A, Partnerships

Neogen acquires its distributors in Argentina and Uruguay

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Jan. 6, 2020 — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Productos Quimicos Magiar (Magiar) — a distributor of Neogen’s food safety diagnostics for the past 20 years with businesses in Argentina and Uruguay. With the acquisition, the former Magiar operations will stay in the... Read more

January 6, 2020 Clinical Research/Diagn. M&A, Partnerships

Abcam announces successful acquisition of Expedeon’s Proteomics and Immunology business, enhancing its conjugation capability

Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSureTM Opportunity to combine Expedeon and Abcam’s technologies to create new products to support research and diagnostic development Cambridge, UK, -06 January 2020: Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon’s Proteomics... Read more

January 2, 2020 Life Science Tools M&A, Partnerships

Illumina and Pacific Biosciences Announce Termination of Merger Agreement

SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction.... Read more

January 2, 2020 Informatics & Software Lab Top-10 M&A, Partnerships Microscopy PAI Top-10

Enhanced Chromatography Data System Software Delivers Improved Efficiency and Compatibility Across the Latest Generation of Analytical Instruments

Enhanced Chromatography Data System Software Delivers Improved Efficiency and Compatibility Across the Latest Generation of Analytical Instruments Thermo Fisher Scientific and Agilent Technologies renew commitment to third-party instrument control, maximizing usability in modern chromatography software solutions SAN JOSE, Calif., Jan. 2, 2020 /PRNewswire/ — Thermo Fisher Scientific and Agilent Technologies today announced they are continuing... Read more